Medicine & TechnologyScientists have discovered the relationship between human hair and Cushing Syndrome. Get to know how this Cushing Syndrome became detected in human hair, thus avoiding long-time diagnosis from standard techniques.
If you're among the many who have woken up disoriented, hungover, and sporting a fresh tattoo, here's one more thing to worry about: that body art may cause a skin reaction that can last for months, even years.
Researchers have discovered a method of blocking an enzyme that is used by the disease to spread to the bones and is being described as “important progress” in the prevention of one of the most common and deadly second stages of the disease.
Johnson & Johns is under investigation by the FBI for possible prior knowledge about dangers linked to one of their medical devices, the laparoscopic power morcellator, which is supposed to provide a minimally invasive alternative to hysterectomies and removal of fibroid tumors, but in reality, may have been spreading dangerous forms of cancers among its patients.
Researchers from California are currently experimenting with the street drug, Ecstasy, to see if could help alleviate anxiety for terminally ill patients.
A team of scientists from the University of Sheffield and University of Copenhagen have discovered an enzyme which helps breast cancer spread, and in the process, have found a possible way to prevent the spread of breast cancer-secondary or metastatic cancer-in patients. Bones are the most common routes breast cancer takes as it spreads, involved in about 85 percent of secondary breast cancer cases.
According to a new major trial that could change the way millions of HIV patients are treated, drugs to treat HIV should begin at the moment of diagnosis.
Scientists from the Multidisciplinary Association for Psychedelic Studies (MAPS) are hoping to help 18 terminally ill patients relieve their anxiety, depression, and fear in the next year during extended psychotherapy sessions enhanced by MDMA (ecstasy). The Marin County-based double-blind trial will see subjects test either full doses of MDMA (125 milligrams) or active placebo doses (30 milligrams).
University of Virginia School of Medicine scientists have unraveled the mystery of a strange virus in the hopes of creating more effective tools in the war against human disease. The secret weapon this virus may offer? "Armor" for disease-fighting DNA courtesy of the SIRV2 virus, who calls acid at almost boiling temperatures home.